Efficacy and optimal duration of maintenance immunotherapy following systemic chemoimmunotherapy and locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A multicenter retrospective cohort study

Ähnliche Einträge

• Evaluating the reduction of elective radiotherapy fields for de novo metastatic nasopharyngeal carcinoma in the immunotherapy era
  von: Ting Jin, et al.
  Veröffentlicht: (2024)
• Loco‐regional radiotherapy in de novo metastatic nasopharyngeal carcinoma with chemotherapy and immunotherapy: A real‐world retrospective study from two cancer centers
  von: Li Ma, et al.
  Veröffentlicht: (2024)
• The role of immunochemotherapy maintenance in metastatic nasopharyngeal carcinoma: insights from a cohort study in an endemic region
  von: Zhuoying Luo, et al.
  Veröffentlicht: (2025)
• Comparison of ≥2 lines immunotherapy regimens for recurrent/metastatic nasopharyngeal carcinoma
  von: Lan Peng, et al.
  Veröffentlicht: (2026)
• Precision radiotherapy for nasopharyngeal carcinoma
  von: Zhenyu Zhang, et al.
  Veröffentlicht: (2024)